Stress modulation: Research suggests proposed stress-protective and anxiolytic-like effects [4] [11]
GLP-1RAs act on overlapping hypothalamic circuits, reducing appetite and improving energy balance and have been shown to promote browning of white adipose tissue, contributing to increased energy expenditure
Some patients experience mild oxidative stress as their bodies shift from higher caloric intake to deficit conditions, theoretically creating a window where cellular antioxidant support might matter
Semaglutide is a GLP-1 receptor agonist - it activates one receptor type involved in appetite regulation and insulin secretion
Clinical trial data suggest that higher doses generally produce greater reductions in HbA1c and body weight, but individual response varies considerably
ASK1 goes on to bind to TRAF2, which in turn activates downstream-signaling cascades, including the MKK3/4/6p38 and MKK4/7JNK signaling pathways 36,37 (Figure 4)